Last Posted: Jul 06, 2017
- Recent Patterns in Genetic Testing for Breast and Ovarian Cancer Risk in the U.S.
Han Xuesong et al. American journal of preventive medicine 2017 Jun - Age-specific overall risk of breast, ovarian cancer among women with BRCA1/2 genetic mutations
Science Mag, June 20, 2017 - BRCA1-2 diagnostic workflow from next-generation sequencing technologies to variant identification and final report.
Pilato Brunella et al. Genes, chromosomes & cancer 2016 Oct 55(10) 803-13 - Breast and Ovarian Cancer Penetrance Estimates Derived From Germline Multiple-Gene Sequencing Results in Women
AW Kurian, JCO Precision Oncology, June 27, 2017 - Development and validation of a variant detection workflow for BRCA1 and BRCA2 genes and its clinical application based on the Ion Torrent technology.
Buzolin Ana Lígia et al. Human genomics 2017 Jun 11(1) 14 - Mutation detection rates associated with specific selection criteria for BRCA1/2 testing in 1854 high-risk families: A monocentric Italian study.
Azzollini Jacopo et al. European journal of internal medicine 2016 Jul 3265-71 - The Changing Landscape of Genetic Testing for Inherited Breast Cancer Predisposition.
Afghahi Anosheh et al. Current treatment options in oncology 2017 May 18(5) 27 - Breast and Ovarian Cancer Penetrance Estimates Derived From Germline Multiple-Gene Sequencing Results in Women
AW Kurian, JCO Precision Oncology, June 27, 2017 - Breast and Ovarian Analysis of Disease Incidence and Carrier Estimation Algorithm (BOADICEA)
The Breast and Ovarian Analysis of Disease Incidence and Carrier Estimation Algorithm (BOADICEA) is a computer program that is used to calculate the risks of breast and ovarian cancer in women based on their family history. - Preferences for breast cancer risk reduction among BRCA1/BRCA2 mutation carriers: a discrete-choice experiment.
Liede Alexander et al. Breast cancer research and treatment 2017 Jun - Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Kuchenbaecker Karoline B et al. JAMA 2017 Jun 317(23) 2402-2416 - Breast and ovarian cancer risk and risk reduction in Jewish BRCA1/2 mutation carriers.
Finkelman Brian S et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012 Apr 30(12) 1321-8 - Familial breast cancer: Genetic counseling over time, including patients´ expectations and initiators considering the Angelina Jolie effect.
Evers Christina et al. PloS one 2017 12(5) e0177893 - The Cancer Worry Scale Revised for Breast Cancer Genetic Counseling.
Caruso Anita et al. Cancer nursing 2017 May - A multi-gene panel study in hereditary breast and ovarian cancer in Colombia.
Cock-Rada A M et al. Familial cancer 2017 May - Multigene Panel Testing Provides a New Perspective on Lynch Syndrome.
Espenschied Carin R et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2017 May JCO2016719260
No hay comentarios:
Publicar un comentario